Van der Flier WM - Search Results

1

Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests.

Van Mierlo LD, Wouters H, Sikkes SA, Van der Flier WM, Prins ND, Bremer JA, Koene T, Van Hout HP. Van Mierlo LD, et al. Among authors: van der flier wm, van hout hp. J Alzheimers Dis. 2017;56(1):249-259. doi: 10.3233/JAD-160566. J Alzheimers Dis. 2017. PMID: 27911296 Free PMC article.

2

Cognitive impairment in Alzheimer's disease is modified by APOE genotype.

van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. van der Vlies AE, et al. Among authors: van der flier wm. Dement Geriatr Cogn Disord. 2007;24(2):98-103. doi: 10.1159/000104467. Epub 2007 Jun 26. Dement Geriatr Cogn Disord. 2007. PMID: 17596691

3

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.

Kester MI, Blankenstein MA, Bouwman FH, van Elk EJ, Scheltens P, van der Flier WM. Kester MI, et al. Among authors: van elk ej, van der flier wm. J Alzheimers Dis. 2009;16(3):601-7. doi: 10.3233/JAD-2009-0999. J Alzheimers Dis. 2009. PMID: 19276554

4

Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment.

Tolboom N, van der Flier WM, Yaqub M, Koene T, Boellaard R, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. Tolboom N, et al. Among authors: van berckel bn, van der flier wm. Neurology. 2009 Dec 15;73(24):2079-85. doi: 10.1212/WNL.0b013e3181c679cc. Neurology. 2009. PMID: 20018636

5

Early-versus late-onset Alzheimer's disease: more than age alone.

Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Koedam EL, et al. Among authors: van der vlies ae, van der flier wm. J Alzheimers Dis. 2010;19(4):1401-8. doi: 10.3233/JAD-2010-1337. J Alzheimers Dis. 2010. PMID: 20061618

6

Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects.

Verwey NA, Kester MI, van der Flier WM, Veerhuis R, Berkhof H, Twaalfhoven H, Blankenstein MA, Scheltens And P, Pijnenburg YA. Verwey NA, et al. Among authors: van der flier wm. J Alzheimers Dis. 2010;20(2):445-52. doi: 10.3233/JAD-2010-1392. J Alzheimers Dis. 2010. PMID: 20164558

7

BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.

Mulder SD, van der Flier WM, Verheijen JH, Mulder C, Scheltens P, Blankenstein MA, Hack CE, Veerhuis R. Mulder SD, et al. Among authors: van der flier wm. J Alzheimers Dis. 2010;20(1):253-60. doi: 10.3233/JAD-2010-1367. J Alzheimers Dis. 2010. PMID: 20164582

8

Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer's disease.

Kester MI, van der Flier WM, Mandic G, Blankenstein MA, Scheltens P, Muller M. Kester MI, et al. Among authors: van der flier wm. J Alzheimers Dis. 2010;20(4):1083-90. doi: 10.3233/JAD-2010-091198. J Alzheimers Dis. 2010. PMID: 20413898

9

Clinical characteristics of patients with frontotemporal dementia with and without lobar atrophy on MRI.

Koedam EL, Van der Flier WM, Barkhof F, Koene T, Scheltens P, Pijnenburg YA. Koedam EL, et al. Among authors: van der flier wm. Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):242-7. doi: 10.1097/WAD.0b013e3181cfe326. Alzheimer Dis Assoc Disord. 2010. PMID: 20683185

10

CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.

Reesink FE, Lemstra AW, van Dijk KD, Berendse HW, van de Berg WD, Klein M, Blankenstein MA, Scheltens P, Verbeek MM, van der Flier WM. Reesink FE, et al. Among authors: van de berg wd, van der flier wm, van dijk kd. J Alzheimers Dis. 2010;22(1):87-95. doi: 10.3233/JAD-2010-100186. J Alzheimers Dis. 2010. PMID: 20847452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

697 results

Search Page